Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company focused on obesity care. The Company is advancing four clinical-stage product candidates leveraging multiple GLP-1-based mechanisms of action and routes of administration specifically designed to address critical needs in the current therapeutic landscape with a lead product candidate, ribupatide injection (also known as KAI-9531), that has the potential for weight loss. Ribupatide injection is in global Phase III trials as a once-weekly injectable GLP-1/GIP receptor dual agonist. The Company is developing a once-daily oral tablet formulation, ribupatide oral, to provide a convenient oral option with compelling weight loss among oral treatments. Additionally, it is advancing the development of KAI-7535, a once-daily oral small molecule GLP-1 receptor agonist, and KAI-4729, a once-weekly injectable GLP-1/GIP/glucagon receptor tri-agonist.
Find out what a historical investment in Kailera Therapeutics would be worth today using our KLRA stock calculator.
Buying KLRA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Kailera Therapeutics in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in KLRA
What is the ticker symbol of Kailera Therapeutics?
The ticker symbol for Kailera Therapeutics is KLRA.
How much is one share of KLRA?
One share of KLRA is valued at $11.58 as of 20 November 2026.
What is the market capitalisation of Kailera Therapeutics KLRA?
As of 20 November 2026 Kailera Therapeutics has a market cap of $1.53B.
What is the 52-week high for Kailera Therapeutics stock?
The Kailera Therapeutics 52-week high stock price is $28.23.
What is the 52-week low for Kailera Therapeutics stock?
The Kailera Therapeutics 52-week low stock price is $9.76.
Can I buy KLRA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KLRA shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KLRA on Stake
Buy KLRA from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of KLRA from only US$10 with fractional shares